Vanguard Group Inc Surmodics Inc Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Surmodics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 865,214 shares of SRDX stock, worth $36.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

865,214

Previous 859,287 0.69%

Holding current value

$36.4 Million

Previous $31.2 Million 18.73%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$27.44 - $35.56 $162,636 - $210,764	5,927 Added 0.69%	865,214 $25.4 Million
Q4 2023 Feb 14, 2024	BUY	$28.47 - $38.49 $373,611 - $505,104	13,123 Added 1.55%	859,287 $31.2 Million
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $555,277 - $753,198	19,635 Added 2.38%	846,164 $27.2 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $249,853 - $442,723	14,140 Added 1.74%	826,529 $25.9 Million
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $2.96 Million - $6.65 Million	-172,522 Reduced 17.52%	812,389 $18.5 Million

Q4 2022 Feb 10, 2023	BUY	$29.44 - $37.31 $299,846 - $380,002	10,185 Added 1.04%	984,911 $33.6 Million
Q3 2022 Nov 14, 2022	BUY	$28.84 - $38.92 $457,604 - $617,543	15,867 Added 1.65%	974,726 $29.6 Million
Q2 2022 Aug 12, 2022	BUY	$33.25 - $45.11 $931,698 - $1.26 Million	28,021 Added 3.01%	958,859 $35.7 Million
Q1 2022 May 13, 2022	BUY	$40.68 - $49.72 $968,102 - $1.18 Million	23,798 Added 2.62%	930,838 $42.2 Million
Q4 2021 Feb 14, 2022	SELL	$43.21 - $57.6 $1.02 Million - $1.36 Million	-23,638 Reduced 2.54%	907,040 $43.7 Million
Q3 2021 Nov 12, 2021	SELL	$52.8 - $60.32 $2.5 Million - $2.86 Million	-47,436 Reduced 4.85%	930,678 $51.7 Million
Q2 2021 Aug 13, 2021	BUY	$51.29 - $59.15 $50.2 Million - $57.9 Million	978,114 New	978,114 $53.1 Million

Others Institutions Holding SRDX

# of Institutions

111

Shares Held

12.6M

Call Options Held

200

Put Options Held

4.7K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $589M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Surmodics Inc Transaction History